IFNG and acute myeloid leukemia: We have shown αGalCer is capable to induce a number of critical effects including an increase of iNKT numbers, activation-induced IFN-γ release, a direct iNKT-derived cytotoxicity against AML blasts in vivo, and restoration of T cell function—expanding the rationale from previous in vitro reports [40, 41].